Mease, P. J., Smolen, J. S., Behrens, F., Nash, P., Liu Leage, S., Li, L., . . . Helliwell, P. S. (2020). A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial. Ann Rheum Dis.

Mease, Philip J., et al. "A Head-to-head Comparison of the Efficacy and Safety of Ixekizumab and Adalimumab in Biological-naïve Patients With Active Psoriatic Arthritis: 24-week Results of a Randomised, Open-label, Blinded-assessor Trial." Ann Rheum Dis 2020.

Mease, Philip J., et al. "A Head-to-head Comparison of the Efficacy and Safety of Ixekizumab and Adalimumab in Biological-naïve Patients With Active Psoriatic Arthritis: 24-week Results of a Randomised, Open-label, Blinded-assessor Trial." Ann Rheum Dis 2020.